Rumors swirl, but a Swedish prosecutor will only confirm a “preliminary investigation” into allegations that pharma giant AstraZeneca fixed the Nobels for financial gain.
As for the Nobels, as scurrilous as the charges may sound, there is little evidence to support them. First off, AstraZeneca’s ties to the anti-HPV vaccine are tenuous at best: In 2007 it purchased a company called MedImmune, which had developed the viruslike particle (VLP) technology licensed for use in Merck’s Gardasil and GlaxoSmithKline’s Cervarix vaccines — both designed to prevent HPV infection. The technology, however, is not specific to HPV and companies are working to adapt VLPs and similar techniques for a variety of vaccines, including influenza….
Read the rest…